Literature DB >> 873095

Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes.

J Mirouze, J L Selam, T C Pham, D Cavadore.   

Abstract

With the artificial pancreas used by the authors, insulin was delivered through a venous infusion and the rate of delivery was adjusted according to data provided by a continuous blood glucose monitor. After different trials we selected control algorithms integrating two parameters: instantaneous blood glucose concentration and increasing or decreasing patterns of blood glucose. A constant basal insulin infusion rate was added and improved the control of glycaemic excursions. Different parameters concerning exogenous insulin homoeostasis were determined. The delay to reach an insulin effect was 18+/-2 min and was shortened by a priming-dose at the beginning of the infusion. The insulin effect remained for 28+/-2 min after the infusion had been stopped, but differences were noted in the morning (21+/-2 min), in the afternoon (32+/-2 min) and during the night (25+/-3 min). Insulin needs were evaluated during meals. Related to the amount of carbohydrates, the doses fell from 0.53 units/hr/g of carbohydrate for breakfast to 0.15 for dinner. From these data, it appears that the efficiency of exogenous insulin exhibits a circadian rhythm.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873095     DOI: 10.1007/bf01219712

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  [Development of an automatic system of insulin infusion controlled by blood sugar, its system for the determination of glucose and control algorithms].

Authors:  A H Clemens; P H Chang; R W Myers
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1976-05

2.  [Insulin infusion controlled by continous blood sugar recording].

Authors:  J Mirouze; J L Selam; P Phan Tan Chi
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1976-05

3.  Continuous blood glucose monitoring in insulin-treated diabetes.

Authors:  J Mirouze; F Collard; J L Selam; J Pham
Journal:  Horm Metab Res       Date:  1977       Impact factor: 2.936

4.  Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus.

Authors:  P H Sönksen; M C Srivastava; C V Tompkins; J D Nabarro
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

5.  The half-life of endogenous serum immunoreactive insulin in man.

Authors:  R F Williams; R E Gleason; J S Soeldner
Journal:  Metabolism       Date:  1968-11       Impact factor: 8.694

Review 6.  [The artificial endocrine pancreas in clinical medicine and in research].

Authors:  E F Pfeiffer; W Beischer; C Thum; A H Clemens
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1976-05

7.  Effect of pulse administration of glucose or glucagon on insulin secretion in vitro.

Authors:  G M Grodsky; L L Bennett; D F Smith; F G Schmid
Journal:  Metabolism       Date:  1967-03       Impact factor: 8.694

8.  Regulation of brittle diabetics by a pre-planned insulin infusion programme.

Authors:  T Deckert; B Lorup
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

9.  Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell.

Authors:  W Kerner; C Thum; G Tamás; W Beischer; A H Clemens; E F Pfeiffer
Journal:  Horm Metab Res       Date:  1976-07       Impact factor: 2.936

10.  Treatment of diabetic coma with continuous low-dose infusion of insulin.

Authors:  M M Page; K G Alberti; R Greenwood; K A Gumaa; T D Hockaday; C Lowy; J D Nabarro; D A Pyke; P H Sönksen; P J Watkins; T E West
Journal:  Br Med J       Date:  1974-06-29
View more
  27 in total

1.  AP@home: a novel European approach to bring the artificial pancreas home.

Authors:  Lutz Heinemann; Carsten Benesch; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 2.  AP@home: The Artificial Pancreas Is Now at Home.

Authors:  Lutz Heinemann; Carsten Benesch; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

3.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

4.  DiAs user interface: a patient-centric interface for mobile artificial pancreas systems.

Authors:  Patrick Keith-Hynes; Stephanie Guerlain; Benton Mize; Colleen Hughes-Karvetski; Momin Khan; Molly McElwee-Malloy; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

5.  Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system.

Authors:  J L Selam; D Chenon; T C Pham; J P Gagnol; C Sany; N Thomas; G Gravagne; A Orsetti; J Mirouze
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

6.  Insulin delivery route for the artificial pancreas: subcutaneous, intraperitoneal, or intravenous? Pros and cons.

Authors:  Eric Renard
Journal:  J Diabetes Sci Technol       Date:  2008-07

7.  On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985.

Authors:  E F Pfeiffer
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

8.  Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes. Correction of abnormalities by adequate blood glucose control.

Authors:  J L Selam; J Clot; M Andary; J Mirouze
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

9.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

Authors:  J Mirouze; J L Selam; T C Pham; E Mendoza; A Orsetti
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

10.  Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas.

Authors:  Eric Renard; Jerome Place; Martin Cantwell; Hugues Chevassus; Cesar C Palerm
Journal:  Diabetes Care       Date:  2009-10-21       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.